No Data
No Data
Aurinia Pharmaceuticals(AUPH.US) Director Buys US$12.71 Million in Common Stock
Are Options Traders Betting on a Big Move in Aurinia Pharmaceuticals (AUPH) Stock?
Declining Stock and Decent Financials: Is The Market Wrong About Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH)?
Results: Aurinia Pharmaceuticals Inc. Exceeded Expectations And The Consensus Has Updated Its Estimates
RBC Capital Maintains Aurinia Pharmaceuticals(AUPH.US) With Buy Rating, Cuts Target Price to $8
RBC Lowers Price Target on Aurinia Pharmaceuticals to $8 From $9, Keeps Outperform, Speculative Risk